Cumberland Pharmaceuticals Inc.: revenue
| Value | {"amount": 25549058, "concept": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "currency": "USD"} |
|---|---|
| Period | 2017-01-01 – 2017-12-31 |
| Status | current |
| Entity | Cumberland Pharmaceuticals Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:49:05.543728+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/4368aeea-5bf1-4f42-b4d2-aae97b0c880a
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-20-017370Retrieved: 2026-08-19T10:49:05.543728+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001087294/revenue/2017-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/4368aeea-5bf1-4f42-b4d2-aae97b0c880a
History
- supersedes {"amount": 40376563, "concept": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "currency": "USD"} (evidence 0001628280-19-002785)